Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023) is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023) has participated in 1 clinical trials.
Therapeutic areas: Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer.
Sponsors: Merck Sharp & Dohme LLC.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023) has 1 clinical trials on record. Their work covers Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer.
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0023) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.